Dawn Christine Maroney, President of Alignment Healthcare, Inc., filed a Form 4 on August 18, 2026, disclosing the sale of 5,000 shares of common stock on August 14, 2026, under a pre-established Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Dawn Christine Maroney, President of Alignment Healthcare, Inc. (NASDAQ:ALHC)
  • Transaction: 5,000 shares of common stock disposed of (transaction code S) on August 14, 2026
  • Sale price: $14 per share, as stated in the filing
  • Remaining ownership: 917,313 shares of common stock held directly following the transaction
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 plan adopted on March 13, 2026
  • Filing date: August 18, 2026, signed by Christopher J. Joyce as Attorney-in-Fact for Dawn C. Maroney

Maroney's Common Stock Sale Under 10b5-1 Plan Reported to the SEC

According to the Form 4 filed with the U.S. Securities and Exchange Commission, Dawn Christine Maroney, serving as President of Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 5,000 shares of the company's common stock on August 14, 2026, at a price of $14 per share. The filing indicates the transaction was a direct disposal, recorded under transaction code S.

The filing discloses that the sale was executed pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), with the plan having been adopted on March 13, 2026. Following the reported transaction, Maroney directly holds 917,313 shares of Alignment Healthcare common stock, according to the filing. No derivative securities transactions were reported in Table II of the form.

The Form 4 was filed on August 18, 2026, and was signed by Christopher J. Joyce as Attorney-in-Fact for Dawn C. Maroney. No amendment date was indicated, suggesting this is an original filing covering the single transaction dated August 14, 2026.

What Was Disclosed

The filing reported one open-market sale of 5,000 shares of Alignment Healthcare common stock by its President, Dawn Christine Maroney, at $14 per share on August 14, 2026, under a 10b5-1 plan adopted March 13, 2026, leaving her with 917,313 shares directly owned.